DUSP4 Silencing Enhances the Sensitivity of Breast Cancer Cells to Doxorubicin through the Activation of the JNK/c-Jun Signalling PathwayMashael S. Al-Mutairi, Hany Onsy Habashy|Molecules|2022Cited by 12